| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aerovate Therapeutics Inc. Common Stock (NASDAQ: AVTE)
AVTE Technical Analysis
4
| As on 9th Jun 2023 AVTE STOCK Price closed @ 15.84 and we RECOMMEND Buy for LONG-TERM with Stoploss of 15.12 & Strong Buy for SHORT-TERM with Stoploss of 9.86 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AVTESTOCK Price
| Open | 16.71 | Change | Price | % |
| High | 16.71 | 1 Day | -0.81 | -4.86 |
| Low | 15.71 | 1 Week | -1.76 | -10.00 |
| Close | 15.84 | 1 Month | -2.93 | -15.61 |
| Volume | 185057 | 1 Year | 6.55 | 70.51 |
| 52 Week High 30.52 | 52 Week Low 8.25 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| AVTE Daily Charts |
AVTE Intraday Charts |
Whats New @ Bazaartrend |
AVTE Free Analysis |
|
|
AVTE Important Levels Intraday
| RESISTANCE | 17.77 |
| RESISTANCE | 17.15 |
| RESISTANCE | 16.77 |
| RESISTANCE | 16.39 |
| SUPPORT | 15.30 |
| SUPPORT | 14.91 |
| SUPPORT | 14.53 |
| SUPPORT | 13.91 |
AVTE Forecast April 2024
| 4th UP Forecast | 27.32 |
| 3rd UP Forecast | 23.64 |
| 2nd UP Forecast | 21.36 |
| 1st UP Forecast | 19.09 |
| 1st DOWN Forecast | 12.59 |
| 2nd DOWN Forecast | 10.32 |
| 3rd DOWN Forecast | 8.04 |
| 4th DOWN Forecast | 4.36 |
AVTE Weekly Forecast
| 4th UP Forecast | 21.00 |
| 3rd UP Forecast | 19.35 |
| 2nd UP Forecast | 18.32 |
| 1st UP Forecast | 17.30 |
| 1st DOWN Forecast | 14.38 |
| 2nd DOWN Forecast | 13.36 |
| 3rd DOWN Forecast | 12.33 |
| 4th DOWN Forecast | 10.68 |
AVTE Forecast2024
| 4th UP Forecast | 60.26 |
| 3rd UP Forecast | 46.01 |
| 2nd UP Forecast | 37.21 |
| 1st UP Forecast | 28.4 |
| 1st DOWN Forecast | 3.28 |
| 2nd DOWN Forecast | -5.53 |
| 3rd DOWN Forecast | -14.33 |
| 4th DOWN Forecast | -28.58 |
Aerovate Therapeutics Inc. Common Stock ( NASDAQ USA Symbol : AVTE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AVTE Business Profile
Aerovate Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs that enhance the lives of patients with rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts. Address: 200 Berkeley Street, Boston, MA, United States, 02116
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service